Balicatib, Catalog: 2596
US$0.00
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide; AAE581
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide; AAE581
Alternate Names N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide; AAE581
Appearance White to off-white solid
CAS # 354813-19-7
Molecular Formula C₂₃H₃₃N₅O₂
Molecular Weight 411.54
Purity > 98% by HPLC
Solubility DMSO (~ 4 mg/ml)
SMILES CCCN1CCN(C2=CC=C(C(NC3(C(NCC#N)=O)CCCCC3)=O)C=C2)CC1
InChi InChI=1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29)
InChi Key LLCRBOWRJOUJAE-UHFFFAOYSA-N
PubChem CID 10201696
Storage Conditions -20 ̊C
Shipping Conditions Gel Pack
Usage For Research Use Only! Not For Use in Humans.
Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.
Cell-permeable. Balicatib is a potent human cathepsin K inhibitor in vitro (IC₅₀ = 1.4 nM) with a high selectivity against human cathepsins B, L, and S (> 4,800-fold, > 500-fold and > 65,000-fold, respectively).